Bone hydatid disease refractory to nitazoxanide treatment

Am J Trop Med Hyg. 2009 Sep;81(3):446-8.

Abstract

We report a patient with bone hydatid disease that was refractory to both long-term daily treatment with albendazole, combined with cimetidine or administered as monotherapy ( approximately 15 years) and a relatively short course of nitazoxanide combined with albendazole (3 months). Despite continuous daily medical treatment, bone invasion and destruction proceeded. His pain and disability progressively increased.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Albendazole / administration & dosage
  • Albendazole / therapeutic use
  • Anthelmintics / administration & dosage
  • Anthelmintics / therapeutic use*
  • Bone Diseases / drug therapy*
  • Bone Diseases / parasitology
  • Bone Diseases / pathology
  • Cimetidine / administration & dosage
  • Cimetidine / therapeutic use
  • Drug Resistance*
  • Echinococcosis / complications
  • Echinococcosis / drug therapy*
  • Echinococcosis / pathology
  • Histamine H2 Antagonists / administration & dosage
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Lumbar Vertebrae / parasitology
  • Lumbar Vertebrae / pathology
  • Lumbar Vertebrae / surgery
  • Male
  • Nitro Compounds
  • Thiazoles / administration & dosage
  • Thiazoles / therapeutic use*

Substances

  • Anthelmintics
  • Histamine H2 Antagonists
  • Nitro Compounds
  • Thiazoles
  • Cimetidine
  • Albendazole
  • nitazoxanide